|
Market Closed -
Nasdaq
04:00:00 2026-09-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 14.60 USD | +3.11% |
|
+2.60% | -16.52% |
| Market Cap | 8.62B 11.65B 10.05B 9.47B 16.12B 1,100B 16.24B 112B 43.49B 563B 43.74B 42.78B 1,848B | P/E 2026 * |
-12.5x | P/E 2027 * | -12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 8.16B 11.02B 9.5B 8.95B 15.25B 1,041B 15.36B 106B 41.13B 532B 41.37B 40.46B 1,748B | EV / Sales 2026 * |
2,791x | EV / Sales 2027 * | 202x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Summit Therapeutics Inc.
| 1 day | +3.11% | ||
| 1 week | +2.60% | ||
| Current month | +7.20% | ||
| 1 month | +12.14% | ||
| 3 months | -1.75% | ||
| 6 months | -9.82% | ||
| Current year | -16.52% |
| 1 week | 13.37 |  | 14.72 |
| 1 month | 12.07 | | 15.75 |
| Current year | 12.07 | | 29.23 |
| 1 year | 12.07 | | 29.23 |
| 3 years | 1.52 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 2022-07-24 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 2020-03-31 |
| Director of Finance/CFO | 48 | 2024-04-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 2020-01-31 |
| Director/Board Member | 48 | 2019-11-30 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 2020-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/4/26 | Buy | Chief Executive Officer | 100,000 | 0.0129% | ||
| 6/4/26 | Buy | Chief Executive Officer | 100,000 | 0.0129% | ||
| 6/4/26 | Buy | Chief Financial Officer | 50,000 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.11% | +2.60% | -38.76% | +795.71% | 11.65B | |
| +1.03% | -2.05% | +39.28% | +94.60% | 68.87B | |
| +1.53% | +0.75% | +49.77% | +92.50% | 65.29B | |
| +4.21% | +1.80% | -12.85% | +459.32% | 27.65B | |
| +2.97% | +0.40% | +38.60% | +12.79% | 25.77B | |
| +1.83% | -7.77% | +3.17% | -14.74% | 26.08B | |
| +1.77% | +2.08% | +27.35% | -16.94% | 20.14B | |
| -0.38% | -17.67% | +214.37% | +373.18% | 17.03B | |
| +0.77% | -5.28% | -3.25% | +539.79% | 15.03B | |
| +2.88% | +4.33% | +57.42% | +157.39% | 14.5B | |
| Average | +1.97% | -2.51% | +37.51% | +249.36% | 29.2B | |
| Weighted average by Cap. | +1.81% | -2.15% | +38.39% | +174.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.92M 3.95M 3.41M 3.21M 5.46M 373M 5.5M 37.98M 14.74M 191M 14.82M 14.5M 626M | 41.7M 56.32M 48.59M 45.77M 77.95M 5.32B 78.53M 542M 210M 2.72B 211M 207M 8.94B |
| Net income | -689M -931M -803M -756M -1.29B -87.93B -1.3B -8.96B -3.48B -44.95B -3.5B -3.42B -148B | -729M -984M -849M -800M -1.36B -92.99B -1.37B -9.47B -3.68B -47.55B -3.7B -3.62B -156B |
| Net Debt | -467M -631M -544M -513M -873M -59.62B -880M -6.07B -2.36B -30.48B -2.37B -2.32B -100B | -199M -268M -231M -218M -371M -25.33B -374M -2.58B -1B -12.95B -1.01B -985M -42.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | $14.60 | +3.11% | 3,779,231 |
| 26-09-01 | $14.16 | +3.96% | 4,703,282 |
| 26-08-31 | $13.62 | -0.80% | 5,425,208 |
| 26-08-28 | $13.73 | -4.19% | 3,906,883 |
| 26-08-27 | $14.33 | +0.70% | 4,838,165 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SMMT Stock
Select your edition
All financial news and data tailored to specific country editions
